Literature DB >> 4988693

Effect of massive doses of bacteriophage on excretion of vibrios, duration of diarrhoea and output of stools in acute cases of cholera.

K A Monsur, M A Rahman, F Huq, M N Islam, R S Northrup, N Hirschhorn.   

Abstract

Each member of a group of 8 patients with acute cholera was treated with a mixture of four cholera bacteriophage preparations containing over 2 x 10(12) phage particles/ml. These massive doses were intended to kill immediately all vibrios in the intestine by "lysis from without". The numbers of Vibrio cholerae were drastically reduced rapidly. In 4 patients, V. cholerae was completely eliminated from the stools early in the treatment; the total stool volume and after-treatment of diarrhoea were reduced in comparison with a control group but were higher than in a group of patients treated with tetracycline. In the other 4 patients treated with phage, vibrios disappeard more slowly from the stools and there was no apparent clinical effect of the phage. In all the patients treated with phage, the duration of diarrhoea was longer than in patients in a control group who excreted vibrios for a similar length of time although the stool output was similar. This was interpreted as being due to the persistence of vibrios in foci of infection in the upper intestine.It is concluded that treatment of cholera with massive doses of bacteriophage is not as effective as treatment with tetracycline. However, phage can selectively eliminate the majority of vibrios without affecting the other intestinal flora and without any apparent toxic effect on the patient. Phage might therefore be useful as a research tool.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4988693      PMCID: PMC2427496     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  6 in total

1.  WATER AND ELECTROLYTE LOSSES IN CHOLERA.

Authors:  R A PHILLIPS
Journal:  Fed Proc       Date:  1964 May-Jun

2.  Treatment and prophylaxis of cholera with bacteriophage.

Authors:  R M SAYAMOV
Journal:  Bull World Health Organ       Date:  1963       Impact factor: 9.408

3.  A highly selective gelatin-taurocholate-tellurite medium for the isolation of Vibrio cholerae.

Authors:  K A MONSUR
Journal:  Trans R Soc Trop Med Hyg       Date:  1961-09       Impact factor: 2.184

4.  Characterization of the cholera typing phages. III: Some observations on their dynamics of generation.

Authors:  S MUKERJEE
Journal:  Ann Biochem Exp Med       Date:  1961-09

5.  THE GROWTH OF BACTERIOPHAGE AND LYSIS OF THE HOST.

Authors:  M Delbrück
Journal:  J Gen Physiol       Date:  1940-05-20       Impact factor: 4.086

6.  Decrease in net stool output in cholera during intestinal perfusion with glucose-containing solutions.

Authors:  N Hirschhorn; J L Kinzie; D B Sachar; R S Northrup; J O Taylor; S Z Ahmad; R A Phillips
Journal:  N Engl J Med       Date:  1968-07-25       Impact factor: 91.245

  6 in total
  14 in total

1.  Reviving Phage Therapy for the Treatment of Cholera.

Authors:  Sudhakar Bhandare; Joan Colom; Abiyad Baig; Jenny M Ritchie; Habib Bukhari; Muhammad A Shah; Banwarilal L Sarkar; Jingliang Su; Brendan Wren; Paul Barrow; Robert J Atterbury
Journal:  J Infect Dis       Date:  2019-02-15       Impact factor: 5.226

Review 2.  Pharmacologically Aware Phage Therapy: Pharmacodynamic and Pharmacokinetic Obstacles to Phage Antibacterial Action in Animal and Human Bodies.

Authors:  Krystyna Dąbrowska; Stephen T Abedon
Journal:  Microbiol Mol Biol Rev       Date:  2019-10-30       Impact factor: 11.056

Review 3.  Biological foundations of successful bacteriophage therapy.

Authors:  Carola Venturini; Aleksandra Petrovic Fabijan; Alicia Fajardo Lubian; Stefanie Barbirz; Jonathan Iredell
Journal:  EMBO Mol Med       Date:  2022-05-27       Impact factor: 14.260

4.  Clinical studies of the use of bacteriophage in the treatment of cholera.

Authors:  L M Marcuk; V N Nikiforov; J F Scerbak; T A Levitov; R I Kotljarova; M S Naumsina; S U Davydov; K A Monsur; M A Rahman; M A Latif; R S Northrup; R A Cash; I Hug; C R Dey; R A Phillips
Journal:  Bull World Health Organ       Date:  1971       Impact factor: 9.408

5.  Modeling the role of bacteriophage in the control of cholera outbreaks.

Authors:  Mark A Jensen; Shah M Faruque; John J Mekalanos; Bruce R Levin
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-14       Impact factor: 11.205

Review 6.  Insights into Bacteriophage Application in Controlling Vibrio Species.

Authors:  Vengadesh Letchumanan; Kok-Gan Chan; Priyia Pusparajah; Surasak Saokaew; Acharaporn Duangjai; Bey-Hing Goh; Nurul-Syakima Ab Mutalib; Learn-Han Lee
Journal:  Front Microbiol       Date:  2016-07-19       Impact factor: 5.640

Review 7.  Phage Therapy in Bacterial Infections Treatment: One Hundred Years After the Discovery of Bacteriophages.

Authors:  Agata Anna Cisek; Iwona Dąbrowska; Karolina Paulina Gregorczyk; Zbigniew Wyżewski
Journal:  Curr Microbiol       Date:  2016-11-28       Impact factor: 2.188

Review 8.  Phage therapy: What factors shape phage pharmacokinetics and bioavailability? Systematic and critical review.

Authors:  Krystyna Dąbrowska
Journal:  Med Res Rev       Date:  2019-03-19       Impact factor: 12.944

9.  Bacteriophage as an Alternative to Antibiotics Promotes Growth Performance by Regulating Intestinal Inflammation, Intestinal Barrier Function and Gut Microbiota in Weaned Piglets.

Authors:  Yongdi Zeng; Zirui Wang; Tiande Zou; Jun Chen; Guanhong Li; Liuzhen Zheng; Shuo Li; Jinming You
Journal:  Front Vet Sci       Date:  2021-01-27

Review 10.  Phage Therapy for Mycobacterium Abscessus and Strategies to Improve Outcomes.

Authors:  Abdolrazagh Hashemi Shahraki; Mehdi Mirsaeidi
Journal:  Microorganisms       Date:  2021-03-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.